Clínica y fisiopatología | 09 FEB 20

Influencia del género en las enfermedades cardiovasculares

El dolor precordial y la enfermedad coronaria. Mecanismos y diferencias entre ambos sexos.
Autor/a: Puja K. Mehta, Courtney Bess, Suzette Elias-Smale y colaboradores European Heart Journal (2019) 0, 1–8
INDICE:  1. Texto principal | 2. Referencias bibliográficas
Referencias bibliográficas

1. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O’Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation 2019;139:e56–e528.

2. Timmis A, Townsend N, Gale C, Grobbee R, Maniadakis N, Flather M, Wilkins E, Wright L, Vos R, Bax J, Blum M, Pinto F, Vardas P, Goda A, Demiraj AF, Weidinger F, Metzler B, Ibrahimov F, Pasquet AA, Claeys M, Thorton Y,

Kusljugic Z, Smajic E, Velchev V, Ivanov N, Antoniades L, Agathangelou P, Ta´borsk_y M, Gerdes C, Viigima M, Juhani PM, Juilliere Y, Cattan S, Aladashvili A, Hamm C, Kuck K-H, Papoutsis K, Bestehorn K, Foussas S, Giannoulidou G, Varounis C, Kallikazaros I, Kiss RG, Cze´te´nyi T, Becker D, Gudnason T, Kearney P, McDonald K, Rozenman Y, Ziv B, Bolognese L, Luciolli P, Boriani G, Berkinbayev S, Rakisheva A, Mirrakhimov E, Erglis A, Jegere S, Marinskis G, Beissel J, Marchal N, Kedev S, Xuereb RG, Tilney T, Felice T, Popovici M, Bax J, Mulder B, Simoons M, Elsendoorn M, Steigen TK, Atar D, Kalarus Z, Tendera M, Cardoso JS, Ribeiro J, Mateus C, Tatu-Chitoiu G, Seferovic P, Beleslin B, Simkova I, Durcikova P, Belicova V, Fras Z, Radelj S, Gonzalez Juanatey JR, Legendre S, Braunschweig F, Kaufmann UP, Rudiger-Sturchler M, Tokgozoglu L, Unver A, Kovalenko V, Nesukay E, Naum A, de Courtelary PT, Martin S, Sebastiao D, Ghislain D, Bardinet I, Logstrup S; ESC Scientific Document Group. European Society of Cardiology: cardiovascular disease statistics 2017. Eur Heart J 2018;39:

508–579.

3. Bugiardini R, Ricci B, Cenko E, Vasiljevic Z, Kedev S, Davidovic G, Zdravkovic M, Mili_ci_c D, Dilic M, Manfrini O, Koller A, Badimon L. Delayed care and mortality among women and men with myocardial infarction. J Am Heart Assoc 2017;6: e005968.

4. Dreyer RP, Beltrame JF, Tavella R, Air T, Hoffmann B, Pati PK, Di Fiore D, Arstall M, Zeitz C. Evaluation of gender differences in door-to-balloon time in STeleve tion myocardial infarction. Heart Lung Circ 2013;22:861–869.

5. Virani SS, Woodard LD, Ramsey DJ, Urech TH, Akeroyd JM, Shah T, Deswal A, Bozkurt B, Ballantyne CM, Petersen LA. Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. Am J Cardiol 2015;115: 21–26.

6. Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, Fabunmi RP, Kwan J, Mills T, Simpson SL. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005;111: 499–510.

7. Scott PE, Unger EF, Jenkins MR, Southworth MR, McDowell TY, Geller RJ, Elahi M, Temple RJ, Woodcock J. Participation of women in clinical trials supporting FDA approval of cardiovascular drugs. J Am Coll Cardiol 2018;71:1960–1969.

8. Shahin M, Obeid S, Hamed L, Templin C, Gamperli O, Nietlispach F, Maier W, Yousif N, Mach F, Roffi M, Windecker S, Raber L, Matter CM, Luscher TF. Occurrence and impact of time delay to primary percutaneous coronary intervention in patients with ST-Segment elevation myocardial infarction. Cardiol Res 2017;8:190–198.

9. Mahmoud KD, Gu YL, Nijsten MW, de Vos R, Nieuwland W, Zijlstra F, Hillege HL, van der Horst IC, de Smet BJ. Interhospital transfer due to failed prehospital diagnosis for primary percutaneous coronary intervention: an observational study on incidence, predictors, and clinical impact. Eur Heart J Acute Cardiovasc Care 2013;2:166–175.

10. Melberg T, Kindervaag B, Rosland J. Gender-specific ambulance priority and delays to primary percutaneous coronary intervention: a consequence of the patients’ presentation or the management at the emergency medical communications center? Am Heart J 2013;166:839–845.

11. D’Onofrio G, Safdar B, Lichtman JH, Strait KM, Dreyer RP, Geda M, Spertus JA, Krumholz HM. Sex differences in reperfusion in young patients with ST-segmentelevation myocardial infarction: results from the VIRGO study. Circulation 2015; 131:1324–1332.

12. Ghadri JR, Sarcon A, Jaguszewski M, Diekmann J, Bataiosu RD, Hellermann J, Csordas A, Baumann L, Schoni AA, Luscher TF, Templin C. Gender disparities in acute coronary syndrome: a closing gap in the short-term outcome. J Cardiovasc Med (Hagerstown) 2015;16:355–362.

13. Roswell RO, Kunkes J, Chen AY, Chiswell K, Iqbal S, Roe MT, Bangalore S. Impact of sex and contact-to-device time on clinical outcomes in acute  STsegment elevation myocardial infarction-findings from the national cardiovascular data registry. J Am Heart Assoc 2017;6:e004521.

14. Greenwood BN, Carnahan S, Huang L. Patient–physician gender concordance and increased mortality among female heart attack patients. Proc Natl Acad Sci USA 2018;115:8569.

15. Wei J, Mehta PK, Grey E, Garberich RF, Hauser R, Bairey Merz CN, Henry TD. Sex-based differences in quality of care and outcomes in a health system using a standardized STEMI protocol. Am Heart J 2017;191:30–36.

16. Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Pepine CJ, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Lerman A, Quyyumi AA, Sopko G. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of aterosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 2006; 47(3 Suppl): S21–S29.

17. Chaitman BR, Bourassa MG, Davis K, Rogers WJ, Tyras DH, Berger R, Kennedy JW, Fisher L, Judkins MP, Mock MB, Killip T. Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation 1981;64:360–367.

18. Diamond GA. A clinically relevant classification of chest discomfort. J Am Coll Cardiol 1983;1:574–575.

19. Pacheco Claudio C, Quesada O, Pepine CJ, Noel Bairey Merz C. Why ames matter for women: MINOCA/INOCA (myocardial infarction/ischemia and no obstructive coronary artery disease). Clin Cardiol 2018;41:185–193.

20. Arau´jo C, Laszczy_nska O, Viana M, Mel~ao F, Henriques A, Borges A, Severo M, Maciel MJ, Moreira I, Azevedo A. Sex differences in presenting symptoms of acute coronary syndrome: the EPIHeart cohort study. BMJ Open 2018;8: e018798.

21. Arslanian-Engoren C, Patel A, Fang J, Armstrong D, Kline-Rogers E, Duvernoy CS, Eagle KA. Symptoms of men and women presenting with acute coronary syndromes. Am J Cardiol 2006;98:1177–1181.

22. Wenger NK. Clinical presentation of CAD and myocardial ischemia in women. J Nucl Cardiol 2016;23:976–985.

23. Lichtman JH, Leifheit-Limson EC, Watanabe E, Allen NB, Garavalia B, Garavalia LS, Spertus JA, Krumholz HM, Curry LA. Symptom recognition and healthcare experiences of young women with acute myocardial infarction. Circ Cardiovasc Qual Outcomes 2015;8(2 Suppl 1): S31–S38.

24. Nugent L, Mehta PK, Bairey Merz CN. Gender and microvascular angina.

J Thromb Thrombolysis 2011;31:37–46.

25. Sharaf BL, Pepine CJ, Kerensky RA, Reis SE, Reichek N, Rogers WJ, Sopko G, Kelsey SF, Holubkov R, Olson M, Miele NJ, Williams DO, Merz CN, Group WS. Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory). Am J Cardiol 2001;87:937–941; A933.

26. Merz CN, Kelsey SF, Pepine CJ, Reichek N, Reis SE, Rogers WJ, Sharaf BL, Sopko G. The Women’s Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol 1999;33:1453–1461.

27. Handberg EM, Eastwood JA, Eteiba W, Johnson BD, Krantz DS, Thompson DV, Vaccarino V, Bittner V, Sopko G, Pepine CJ, Merz NB, Rutledge TR. Clinical implications of the Women’s Ischemia Syndrome Evaluation: inter-relationships between symptoms, psychosocial factors and cardiovascular outcomes. Womens Health (Lond) 2013;9:479–490.

28. Szpakowski N, Bennell M, Qiu F, Ko D, Tu J, Kurdyak P, Wijeysundera H. Clinical impact of subsequent depression in patients with a new diagnosis of stable angina: a population-based study. Circ Cardiovasc Qual Outcomes 2016;9:731–739.

29. Shaw L, Merz N, Pepine C, Reis S, Bittner V, Kip K, Kelsey S, Olson M, Johnson D, Mankad S, Sharaf B, Rogers W, Pohost G, Sopko G. The economic burden of angina in women with suspected ischemic heart disease. Circulation 2006;114: 894–904.

30. Al-Lamee R, Thompson D, Dehbi HM, Sen S, Tang K, Davies J, Keeble T, Mielewczik M, Kaprielian R, Malik IS, Nijjer SS, Petraco R, Cook C, Ahmad Y, Howard J, Baker C, Sharp A, Gerber R, Talwar S, Assomull R, Mayet J, Wensel R, Collier D, Shun-Shin M, Thom SA, Davies JE, Francis DP; ORBITA Investigators. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet 2018;391:31–40.

31. Rajkumar CA, Nijjer SS, Cole GD, Al-Lamee R, Francis DP. Moving the goalposts into unblinded territory: the larger lessons of DEFER and FAME 2 and their implications for shifting end points in ISCHEMIA. Circ Cardiovasc Qual Outcomes 2018;11:e004665.

32. De Bruyne B, Pijls NHJ, Kalesan B, Barbato E, Tonino PAL, Piroth Z, Jagic N, Mo¨bius-Winkler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engstro¨m T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Ju¨ni P, Fearon WF; FAME 2 Trial Investigators. Fractional Flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012;367:991–1001.

33. Krantz DS, Hedges SM, Gabbay FH, Klein J, Falconer JJ, Merz CN, Gottdiener JS, Lutz H, Rozanski A. Triggers of angina and ST-segment depression in ambulatory patients with coronary artery disease: evidence for an uncoupling of angina and ischemia. Am Heart J 1994;128:703–712.

34. Pepine CJ. Does the brain know when the heart is ischemic? Ann Intern Med 1996;124:1006–1008.

35. Schang SJ Jr, Pepine CJ. Transient asymptomatic S-T segment depression during daily activity. Am J Cardiol 1977;39:396–402.

36. Gottlieb SO, Gottlieb SH, Achuff SC, Baumgardner R, Mellits ED, Weisfeldt ML, Gerstenblith G. Silent ischemia on Holter monitoring predicts mortality in highrisk postinfarction patients. JAMA 1988;259:1030–1035.

37. Aronow WS, Epstein S. Usefulness of silent myocardial ischemia detected by ambulatory electrocardiographic monitoring in predicting new coronary events in elderly patients. Am J Cardiol 1988;62:1295–1296.

38. Langer A, Freeman MR, Armstrong PW. ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome. J Am Coll Cardiol 1989;13:1495–1502.<

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024